| Date |
Headline/Title |
| 12 December 2022 | Aspen, CEPI and the Bill & Melinda Gates Foundation expand commitments to improve access to vaccines in Africa |
| 08 December 2022 | Report on Annual General Meeting proceedings |
| 10 November 2022 | Broad-Based Black Economic Empowerment Certificate for the year ended 30 June 2022 |
| 08 November 2022 | Aspen closes EUR 1.26bn equivalent Syndicated Loan Facilities |
| 03 November 2022 | Dealing in Aspen Securities by a Director, Prescribed Officer, and the Company Secretary of the Company |
| 01 November 2022 | Notification in terms of Section 122(3) of the Companies Act and paragraph 3.83(b) of the JSE Listings Requirements |
| 28 October 2022 | Release of Integrated Report and further notice of Annual General Meeting to be held on 8 December 2022 |
| 25 October 2022 | Delivery of securities to directors, company secretary, and prescribed officers of the company |
| 21 October 2022 | Dealing in Aspen Securities |
| 04 October 2022 | Release Of Annual Financial Statements, Change Statement and Notice of Annual General Meeting on 8 December 2022 |
| 15 September 2022 | Dealing in securities by Directors, Prescribed Officers and the Company Secretary of the Company |
| 31 August 2022 | Aspen final results June 2022 |
| 31 August 2022 | Aspen concludes a collaboration agreement to manufacture and make available four Aspen-Branded vaccines for Africa |
| 23 August 2022 | Reminder of the release of the Annual Financial Results for the year ended 30 June 2022 and a Live Presentation |
| 17 August 2022 | Trading Statement for the Financial Year ended 30 June 2022 |
| 06 April 2022 | Dealing in Aspen Securities by a Director, the Company Secretary, and Prescribed Officers of the Company |
| 06 April 2022 | Dealing in Aspen Securities by a Prescribed Officer of the Company |
| 01 April 2022 | Vesting of securities for directors, company secretary and prescribed officers of the company |
| 28 March 2022 | Dealing in Aspen Securities |
| 09 March 2022 | Aspen interim results December 2021 |
| 08 March 2022 | Aspen concludes agreement to manufacture and make available an Aspen-branded Covid-19 vaccine (Aspenovax) |
| 08 March 2022 | Appointment of Yvonne Muthien as member of the Social & Ethics Committee |
| 01 March 2022 | Completion of divestment of a portfolio of six South African products to Acino |
| 28 February 2022 | Aspen’s Interim Results for the six months ended 31 December 2021 and Results presentation reminder |
| 01 February 2022 | Trading Statement in respect of Aspen’s results for the six months ended 31 December 2021 |
| 18 January 2022 | Business update for the six months ended 31 December 2021 and withdrawal of cautionary announcement |